Sunny Pharmtech Inc. (TPEX:6676)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.75
+1.35 (10.07%)
May 8, 2026, 1:56 PM CST

Sunny Pharmtech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
253.01418.01428.83359.59241
Revenue Growth (YoY)
-39.47%-2.52%19.26%49.21%-42.61%
Cost of Revenue
179.87191.61143.3152.88125.25
Gross Profit
73.14226.4285.53206.71115.75
Selling, General & Admin
163.81170.11148.76138.45120.39
Research & Development
226.86219.28208.87255.88171.37
Operating Expenses
390.66389.39357.62394.33291.75
Operating Income
-317.53-162.99-72.1-187.62-176
Interest Expense
-10.36-9.07-11.24-4.59-5.62
Interest & Investment Income
2.124.545.731.380.36
Currency Exchange Gain (Loss)
-10.7412.2316.15-3.18
Other Non Operating Income (Expenses)
23.720.73.384.533.31
EBT Excluding Unusual Items
-302.05-156.08-62-170.15-181.14
Gain (Loss) on Sale of Assets
-0.08-0.08-0.09-
Asset Writedown
---1.24--
Other Unusual Items
----4.48
Pretax Income
-302.05-156-63.32-170.24-174.79
Net Income
-302.05-156-63.32-170.24-174.79
Net Income to Common
-302.05-156-63.32-170.24-174.79
Shares Outstanding (Basic)
149149143139134
Shares Outstanding (Diluted)
149149143139134
Shares Change (YoY)
0.04%4.20%3.04%3.60%3.29%
EPS (Basic)
-2.03-1.05-0.44-1.23-1.31
EPS (Diluted)
-2.03-1.05-0.44-1.23-1.31
Free Cash Flow
-188.32-82.81-105.88-152.3-193.31
Free Cash Flow Per Share
-1.27-0.56-0.74-1.10-1.45
Gross Margin
28.91%54.16%66.58%57.48%48.03%
Operating Margin
-125.50%-38.99%-16.81%-52.18%-73.03%
Profit Margin
-119.38%-37.32%-14.77%-47.34%-72.53%
Free Cash Flow Margin
-74.43%-19.81%-24.69%-42.35%-80.21%
EBITDA
-189.95-48.4541.34-83.09-76.24
EBITDA Margin
-75.08%-11.59%9.64%-23.11%-31.64%
D&A For EBITDA
127.58114.54113.44104.5399.76
EBIT
-317.53-162.99-72.1-187.62-176
EBIT Margin
-125.50%-38.99%-16.81%-52.18%-73.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.